Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 21.2% during mid-day trading on Friday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares traded hands during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Down 10.0 %

The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a market capitalization of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32. The business has a fifty day moving average price of C$0.11 and a 200 day moving average price of C$0.08.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.